ISSN: 2149-2247 | E-ISSN: 2149-2549

Quick Search




Current Antiretroviral Therapies and Future Trends in Management of Human Immunodeficiency Virus-1 Infection [Erciyes Med J]
Erciyes Med J. 2019; 41(1): 5-11 | DOI: 10.14744/etd.2019.19210

Current Antiretroviral Therapies and Future Trends in Management of Human Immunodeficiency Virus-1 Infection

Naomi S Bulteel, Clifford Leen
Regional Infectious Diseases Unit, Western General Hospital, Edinburgh, United Kingdom of Great Britain and Northern Ireland

Earlier initiation of antiretroviral therapy (ART) for human immunodeficiency virus (HIV)-1 infection is associated with reduced HIV-related morbidity and mortality, improved immune recovery, and reduced risk of HIV-1 transmission. Consequently, international guidelines now recommend ART for all HIV-1-infected adults, regardless of CD4 cell count. The shift in guidance has led to concern regarding long-term ART toxicity, and new strategies to limit ART exposure have been proposed. In this review, we will discuss current recommendations for ART and future trends in management including mono- and dual-therapy, new ART formulations, and novel antiretroviral agents.

Keywords: HIV, AIDS, antiretroviral therapy

Naomi S Bulteel, Clifford Leen. Current Antiretroviral Therapies and Future Trends in Management of Human Immunodeficiency Virus-1 Infection. Erciyes Med J. 2019; 41(1): 5-11

Corresponding Author: Naomi S Bulteel, Türkiye
LookUs & Online Makale